Suchergebnisse - "Su, Jinming"

PubPharm (7)

1

Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China : a cross-sectional survey

enthalten in: BMC infectious diseases | 2022

von Su, J. | Jia, Z. | Wang, X. | +13

2

Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey

enthalten in: BMC infectious diseases | 2022

von Su, J. | Jia, Z. | Wang, X. | +13

3

Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey

enthalten in: BMC infectious diseases | 2022

von Su, J. | Jia, Z. | Wang, X. | +13

4

The Role of Innate Immunity in Natural Elite Controllers of HIV-1 Infection

enthalten in: Frontiers in immunology | 2022

von Shi, Y. | Su, J. | Chen, R. | +7

5

Dolutegravir(DTG, S/GSK1349572) combined with other ARTs is superior to RAL- or EFV-based regimens for treatment of HIV-1 infection: a meta-analysis of randomized controlled trials

enthalten in: AIDS research and therapy | 2016

von Jiang, J. | Xu, X. | Guo, W. | +8

6

Dolutegravir(DTG, S/GSK1349572) combined with other ARTs is superior to RAL- or EFV-based regimens for treatment of HIV-1 infection: a meta-analysis of randomized controlled trials

enthalten in: AIDS research and therapy | 2016

von Jiang, J. | Xu, X. | Guo, W. | +8

7

Dolutegravir(DTG, S/GSK1349572) combined with other ARTs is superior to RAL- or EFV-based regimens for treatment of HIV-1 infection : a meta-analysis of randomized controlled trials

enthalten in: AIDS research and therapy | 2016

von Jiang, J. | Xu, X. | Guo, W. | +8

1
[1]